Impact du complément alimentaire Pendulum T2D sur les symptômes gastro-intestinaux et le contrôle glycémique chez les patients atteints de diabète de type 2

Many people with type 2 diabetes experience gastrointestinal (GI) symptoms, which can negatively impact their quality of life. The cause of these symptoms and their relationship with blood sugar control isn't entirely clear. This study aims to explore if modifying the microbiome using the Pendulum T2D dietary supplement can enhance the effectiveness of current treatments and reduce GI symptoms in type 2 diabetes patients. These patients are already on a stable dose of metformin, either alone or with other oral or injectable anti-hyperglycemic agents, and are experiencing GI symptoms. The study is important as it could potentially lead to improved care and quality of life for those with type 2 diabetes who also have GI symptoms. The study is single-site, observational, and will involve 30 patients with type 2 diabetes who have GI complaints and are using one or more oral or injectable anti-hyperglycemic agents. The study will last for 8 weeks, with an option to continue to 6 months for those who wish to keep taking the dietary supplement. Participants will take the Pendulum T2D supplement, and the study will measure changes in GI symptoms using the Gastrointestinal Symptom Rating Scale (GSRS). This scale assesses the impact of various GI symptoms over the past week, with scores ranging from 1 (no discomfort at all) to 7 (very severe discomfort).